Global Small Molecule Targeted Drugs for Allergic Diseases Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 85
Published Date: 05 Mar 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Small Molecule Targeted Drugs for Allergic Diseases market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Small molecule targeted drugs include JAK inhibitors and TYK2 inhibitors, which exert immunomodulatory effects by blocking the JAK/STAT pathway. Compared with traditional anti-allergic drugs, targeted drugs have better efficacy in severe or drug-resistant patients, and the drugs themselves are safer, and have gradually become the mainstream trend in the development of anti-allergic drugs.
The Global Info Research report includes an overview of the development of the Small Molecule Targeted Drugs for Allergic Diseases industry chain, the market status of Atopic Dermatitis (JAK, TYK2), Asthma (JAK, TYK2), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Small Molecule Targeted Drugs for Allergic Diseases.
Regionally, the report analyzes the Small Molecule Targeted Drugs for Allergic Diseases markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Small Molecule Targeted Drugs for Allergic Diseases market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Small Molecule Targeted Drugs for Allergic Diseases market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Small Molecule Targeted Drugs for Allergic Diseases industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., JAK, TYK2).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Small Molecule Targeted Drugs for Allergic Diseases market.
Regional Analysis: The report involves examining the Small Molecule Targeted Drugs for Allergic Diseases market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Small Molecule Targeted Drugs for Allergic Diseases market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Small Molecule Targeted Drugs for Allergic Diseases:
Company Analysis: Report covers individual Small Molecule Targeted Drugs for Allergic Diseases players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Small Molecule Targeted Drugs for Allergic Diseases This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Atopic Dermatitis, Asthma).
Technology Analysis: Report covers specific technologies relevant to Small Molecule Targeted Drugs for Allergic Diseases. It assesses the current state, advancements, and potential future developments in Small Molecule Targeted Drugs for Allergic Diseases areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Small Molecule Targeted Drugs for Allergic Diseases market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Small Molecule Targeted Drugs for Allergic Diseases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
JAK
TYK2
Market segment by Application
Atopic Dermatitis
Asthma
Others
Market segment by players, this report covers
AbbVie
Pfizer
Novartis
Eli Lilly and Company
LEO Pharma
AstraZeneca
Incyte
Jiangsu Hengrui Pharmaceuticals
Suzhou Zelgen Biopharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Small Molecule Targeted Drugs for Allergic Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Small Molecule Targeted Drugs for Allergic Diseases, with revenue, gross margin and global market share of Small Molecule Targeted Drugs for Allergic Diseases from 2019 to 2024.
Chapter 3, the Small Molecule Targeted Drugs for Allergic Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Small Molecule Targeted Drugs for Allergic Diseases market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Small Molecule Targeted Drugs for Allergic Diseases.
Chapter 13, to describe Small Molecule Targeted Drugs for Allergic Diseases research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Small Molecule Targeted Drugs for Allergic Diseases
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Small Molecule Targeted Drugs for Allergic Diseases by Type
1.3.1 Overview: Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Type in 2023
1.3.3 JAK
1.3.4 TYK2
1.4 Global Small Molecule Targeted Drugs for Allergic Diseases Market by Application
1.4.1 Overview: Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Atopic Dermatitis
1.4.3 Asthma
1.4.4 Others
1.5 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size & Forecast
1.6 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast by Region
1.6.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region, (2019-2030)
1.6.3 North America Small Molecule Targeted Drugs for Allergic Diseases Market Size and Prospect (2019-2030)
1.6.4 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size and Prospect (2019-2030)
1.6.6 South America Small Molecule Targeted Drugs for Allergic Diseases Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size and Prospect (2019-2030)
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
2.1.4 AbbVie Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
2.2.4 Pfizer Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
2.3.4 Novartis Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
2.4.4 Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli Lilly and Company Recent Developments and Future Plans
2.5 LEO Pharma
2.5.1 LEO Pharma Details
2.5.2 LEO Pharma Major Business
2.5.3 LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
2.5.4 LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 LEO Pharma Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
2.6.4 AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Incyte
2.7.1 Incyte Details
2.7.2 Incyte Major Business
2.7.3 Incyte Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
2.7.4 Incyte Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Incyte Recent Developments and Future Plans
2.8 Jiangsu Hengrui Pharmaceuticals
2.8.1 Jiangsu Hengrui Pharmaceuticals Details
2.8.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.8.3 Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
2.8.4 Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Jiangsu Hengrui Pharmaceuticals Recent Developments and Future Plans
2.9 Suzhou Zelgen Biopharmaceuticals
2.9.1 Suzhou Zelgen Biopharmaceuticals Details
2.9.2 Suzhou Zelgen Biopharmaceuticals Major Business
2.9.3 Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
2.9.4 Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Suzhou Zelgen Biopharmaceuticals Recent Developments and Future Plans
3.1 Global Small Molecule Targeted Drugs for Allergic Diseases Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Small Molecule Targeted Drugs for Allergic Diseases by Company Revenue
3.2.2 Top 3 Small Molecule Targeted Drugs for Allergic Diseases Players Market Share in 2023
3.2.3 Top 6 Small Molecule Targeted Drugs for Allergic Diseases Players Market Share in 2023
3.3 Small Molecule Targeted Drugs for Allergic Diseases Market: Overall Company Footprint Analysis
3.3.1 Small Molecule Targeted Drugs for Allergic Diseases Market: Region Footprint
3.3.2 Small Molecule Targeted Drugs for Allergic Diseases Market: Company Product Type Footprint
3.3.3 Small Molecule Targeted Drugs for Allergic Diseases Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value and Market Share by Type (2019-2024)
4.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Forecast by Type (2025-2030)
5.1 Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Application (2019-2024)
5.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Forecast by Application (2025-2030)
6.1 North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2019-2030)
6.2 North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2019-2030)
6.3 North America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country
6.3.1 North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2019-2030)
6.3.2 United States Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
6.3.3 Canada Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
6.3.4 Mexico Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
7.1 Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2019-2030)
7.2 Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2019-2030)
7.3 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country
7.3.1 Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2019-2030)
7.3.2 Germany Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
7.3.3 France Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
7.3.5 Russia Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
7.3.6 Italy Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region
8.3.1 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Region (2019-2030)
8.3.2 China Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
8.3.3 Japan Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
8.3.4 South Korea Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
8.3.5 India Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
8.3.7 Australia Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
9.1 South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2019-2030)
9.2 South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2019-2030)
9.3 South America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country
9.3.1 South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2019-2030)
9.3.2 Brazil Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
9.3.3 Argentina Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country
10.3.1 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2019-2030)
10.3.2 Turkey Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
10.3.4 UAE Small Molecule Targeted Drugs for Allergic Diseases Market Size and Forecast (2019-2030)
11.1 Small Molecule Targeted Drugs for Allergic Diseases Market Drivers
11.2 Small Molecule Targeted Drugs for Allergic Diseases Market Restraints
11.3 Small Molecule Targeted Drugs for Allergic Diseases Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Small Molecule Targeted Drugs for Allergic Diseases Industry Chain
12.2 Small Molecule Targeted Drugs for Allergic Diseases Upstream Analysis
12.3 Small Molecule Targeted Drugs for Allergic Diseases Midstream Analysis
12.4 Small Molecule Targeted Drugs for Allergic Diseases Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
Table 8. AbbVie Small Molecule Targeted Drugs for Allergic Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
Table 13. Pfizer Small Molecule Targeted Drugs for Allergic Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
Table 18. Novartis Small Molecule Targeted Drugs for Allergic Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 21. Eli Lilly and Company Major Business
Table 22. Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
Table 23. Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Eli Lilly and Company Recent Developments and Future Plans
Table 25. LEO Pharma Company Information, Head Office, and Major Competitors
Table 26. LEO Pharma Major Business
Table 27. LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
Table 28. LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. LEO Pharma Recent Developments and Future Plans
Table 30. AstraZeneca Company Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
Table 33. AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. AstraZeneca Recent Developments and Future Plans
Table 35. Incyte Company Information, Head Office, and Major Competitors
Table 36. Incyte Major Business
Table 37. Incyte Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
Table 38. Incyte Small Molecule Targeted Drugs for Allergic Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Incyte Recent Developments and Future Plans
Table 40. Jiangsu Hengrui Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 41. Jiangsu Hengrui Pharmaceuticals Major Business
Table 42. Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
Table 43. Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Jiangsu Hengrui Pharmaceuticals Recent Developments and Future Plans
Table 45. Suzhou Zelgen Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Suzhou Zelgen Biopharmaceuticals Major Business
Table 47. Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product and Solutions
Table 48. Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Suzhou Zelgen Biopharmaceuticals Recent Developments and Future Plans
Table 50. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue (USD Million) by Players (2019-2024)
Table 51. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Share by Players (2019-2024)
Table 52. Breakdown of Small Molecule Targeted Drugs for Allergic Diseases by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Small Molecule Targeted Drugs for Allergic Diseases, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Small Molecule Targeted Drugs for Allergic Diseases Players
Table 55. Small Molecule Targeted Drugs for Allergic Diseases Market: Company Product Type Footprint
Table 56. Small Molecule Targeted Drugs for Allergic Diseases Market: Company Product Application Footprint
Table 57. Small Molecule Targeted Drugs for Allergic Diseases New Market Entrants and Barriers to Market Entry
Table 58. Small Molecule Targeted Drugs for Allergic Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Share by Type (2019-2024)
Table 61. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Forecast by Type (2025-2030)
Table 62. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2019-2024)
Table 63. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Forecast by Application (2025-2030)
Table 64. North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Small Molecule Targeted Drugs for Allergic Diseases Raw Material
Table 95. Key Suppliers of Small Molecule Targeted Drugs for Allergic Diseases Raw Materials
List of Figures
Figure 1. Small Molecule Targeted Drugs for Allergic Diseases Picture
Figure 2. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Type in 2023
Figure 4. JAK
Figure 5. TYK2
Figure 6. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Application in 2023
Figure 8. Atopic Dermatitis Picture
Figure 9. Asthma Picture
Figure 10. Others Picture
Figure 11. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Region in 2023
Figure 16. North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Share by Players in 2023
Figure 22. Small Molecule Targeted Drugs for Allergic Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Small Molecule Targeted Drugs for Allergic Diseases Market Share in 2023
Figure 24. Global Top 6 Players Small Molecule Targeted Drugs for Allergic Diseases Market Share in 2023
Figure 25. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Share by Type (2019-2024)
Figure 26. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share Forecast by Type (2025-2030)
Figure 27. Global Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Share by Application (2019-2024)
Figure 28. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share Forecast by Application (2025-2030)
Figure 29. North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 39. France Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Region (2019-2030)
Figure 46. China Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 49. India Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Small Molecule Targeted Drugs for Allergic Diseases Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Small Molecule Targeted Drugs for Allergic Diseases Consumption Value (2019-2030) & (USD Million)
Figure 63. Small Molecule Targeted Drugs for Allergic Diseases Market Drivers
Figure 64. Small Molecule Targeted Drugs for Allergic Diseases Market Restraints
Figure 65. Small Molecule Targeted Drugs for Allergic Diseases Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Small Molecule Targeted Drugs for Allergic Diseases in 2023
Figure 68. Manufacturing Process Analysis of Small Molecule Targeted Drugs for Allergic Diseases
Figure 69. Small Molecule Targeted Drugs for Allergic Diseases Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
AbbVie Pfizer Novartis Eli Lilly and Company LEO Pharma AstraZeneca Incyte Jiangsu Hengrui Pharmaceuticals Suzhou Zelgen Biopharmaceuticals
05 Mar 2024
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
